Results 11 to 20 of about 1,770 (176)

Femoral Access for Central Venous Port System Implantation [PDF]

Cureus, 2018
Totally implanted venous access port (TIVAP) systems provide adequate quality of care and life, especially for oncology patients. Long-term vascular access is very important and easy to perform, but in some clinical situations, if patients have a superior caval system occlusion, femoral insertion may be the only option.
Cherkashin, Mikhail, Berezina, Natalia, Puchkov, Denis, Suprun, Kirill, Yablonsky, Petr   +4 more
openaire   +2 more sources

Port-exposure management of totally implantable venous access ports: A case report

Journal of Cancer Research and Therapeutics, 2023
ABSTRACT Totally implantable venous access ports (TIVAP) are widely utilized in chemotherapy, parenteral nutrition, and long-lasting intravenous therapy in cancer patients. However, port exposure occurs due to skin damage around the port. Thus, managing port exposure is of great importance; however, it is full of challenges.
Chunqin, Liu, Xiaohua, Liu, Shunying, Zhao, Weifeng, Li   +3 more
openaire   +2 more sources

Success rate and safety of totally implantable access ports placed by the cephalic vein cutdown technique in oncological patients – a single-center study [PDF]

Folia Medica, 2023
Introduction: Totally implantable access ports (TIAPs) are commonly used in oncologic patients undergoing ongoing chemotherapy. The methods of choice for implantation are the subclavian vein puncture approach and the cephalic vein cutdown technique ...
Martin Karamanliev, Tsanko Yotsov, Dobromir Dimitrov   +2 more
doaj   +3 more sources

Septic Pulmonary Emboli Detected by ¹⁸F-FDG PET/CT in a Patient with Central Venous Catheter-Related Staphylococcus aureus Bacteremia

Diagnostics, 2022
We describe a case of 18F-FDG PET/CT detecting septic pulmonary emboli in a patient with Staphylococcus aureus catheter-related bloodstream infection (CRBSI).
Jang Yoo, Miju Cheon
doaj   +1 more source

Thrombosis associated with implantable catheter chamber in cancer patients: report of 3 cases [PDF]

Batna Journal of Medical Sciences
Implantable port-associated thrombosis in cancer patients is the most common non-infectious complication of implantable venous access devices. Their incidence is 1.2 to 13 % in cancer patients.
Ndéye Marième DIAGNE, Elimane Seydi BOUSSO, Djibril Salam DIOUF, Marie Monique TINE, Mame Diarra NDAW, Ibrahima SALL   +5 more
doaj   +1 more source

CLINICAL AND ECONOMIC ANALYSIS OF THE USE OF DIFFERENT TYPES OF SYSTEMS OF VENOUS ACCESS IN THE TREATMENT OF CHILDREN WITH CANCER

Фармакоэкономика, 2015
Introduction. In the article the clinical and economic analysis of the use of different systems of venous access in the treatment of children with cancer.Objective: to conduct clinical and economic analysis systems venous access in order to optimize the ...
Maksim Yur'evich Rykov, Vladimir Georgievich Polyakov   +1 more
doaj   +1 more source

Portacath Implantation in Ghana: Initial Experience at the Komfo Anokye Teaching Hospital in Kumasi

Clinical Medicine Insights: Case Reports, 2022
Current practice for chemotherapy in most oncology departments is the use of dedicated venous access for the continuous and frequent delivery of drugs, fluids and blood products, and the monitoring of the effects of treatment.
Isaac Okyere, Perditer Okyere, Sanjeev Singh, Samuel Gyasi Brenu   +3 more
doaj   +1 more source

Risks of long-term port use in enzyme replacement therapy for lysosomal storage disorders

Molecular Genetics and Metabolism Reports, 2018
Totally implantable vascular access devices (TIVADs) are commonly used in conjunction with enzyme replacement therapy (ERT) for lysosomal storage disorders (LSDs).
Christian J. Hendriksz, Paul Harmatz, Roberto Giugliani, Jane Roberts, G. Suren Arul   +4 more
doaj   +1 more source

Use of Implantable Venous Port Systems in the Treatment of Children with Orphan Diseases (Mucopolysaccharidosis and Pompe Disease): Case Series

Вопросы современной педиатрии, 2015
Many orphan diseases in children require life-long and regular intravenous enzyme replacement therapy. The article describes the first Russian practice of implanting venous port systems in 12 patients with type I and II mucopolysaccharidosis and Pompe ...
M. Yu. Rykov, I. V. Filinov, E. I. Petrov, N. D. Vashakmadze, A. K. Gevorkyan, E. N. Arkhipova, I. V. Sil’nova, E. N. Basargina, N. V. Buchinskaya, A. I. Ivanov, E. A. Isupova, M. M. Kostik, N. A. Abramova, O. V. Kalashnikova, V. G. Chasnyk, A. E. Aleksandrov, D. A. Morozov, V. G. Polyakov   +17 more
doaj   +1 more source

Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports [PDF]

Cochrane Database of Systematic Reviews, 2016
Totally implantable venous access ports (TIVAPs) provide patients with a safe and permanent venous access, for instance in the administration of chemotherapy for oncology patients. There are several methods for TIVAP placement, and the optimal evidence-based method is unclear.To compare the efficacy and safety of three commonly used techniques for ...
Hsu, Charlie C. -T., Kwan, Gigi N. C., Evans-Barns, Hannah, Rophael, John A., van Driel, Mieke L.   +4 more
openaire   +3 more sources